First: Health Ministry Panel wants JnJ to pay at least Rs 20 lakh to patients for faulty implants Ruby Khatun Khatun13 Jan 2018 4:07 PM ISTNew Delhi: Compensation has been recommended by a panel set up by the health ministry, in order to provide relief to patients who received faulty hip...
Bayer, Johnson and Johnson win reversal of 28 million dollars verdict in Xarelto lawsuit Ruby Khatun Khatun11 Jan 2018 10:15 AM ISTA Pennsylvania state court judge on Tuesday overturned a $27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson and Johnson of...
France fines Johnson and Johnson 29.6 million dollars over painkiller patch Ruby Khatun Khatun21 Dec 2017 10:15 AM ISTPARIS: France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) on Wednesday after it ruled...
Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 10:15 AM ISTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
Johnson multiple myeloma drug succeeds in first-line combination study Ruby Khatun Khatun23 Nov 2017 10:00 AM ISTJohnson and Johnson's blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or...
Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report Ruby Khatun Khatun18 Nov 2017 4:31 PM ISTMUMBAI: Eris Life Sciences is going to acquire Stride Shasun India branded formulations business as the company has agreed to sell it for Rs 500 crore...
Johnson and Johnson hit with whooping 247 million dollar fine for defective hip implants Ruby Khatun Khatun18 Nov 2017 2:24 PM ISTNEW YORK: A federal jury in Dallas on Thursday ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who...
Bill Gates makes 100 million dollars personal investment to fight Alzheimer Ruby Khatun Khatun15 Nov 2017 10:25 AM ISTLONDON: Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings...
Johnson and Johnson psoriasis drug gets expanded US approval for teens Ruby Khatun Khatun15 Oct 2017 9:47 AM ISTJohnson and Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients...
Integra LifeScience acquires codman neurosurgery business from Johnson and Johnson Ruby Khatun Khatun6 Oct 2017 9:15 AM ISTPLAINSBORO, N.J.: Integra LifeSciences Holdings Corporation, a global leader in medical technology, announced that it has completed the previously...
Merck to stop development of hepatitis C treatments Ruby Khatun Khatun4 Oct 2017 10:20 AM ISTU.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...
Johnson and Johnson arm Janssen to discontinue Hepatitis C development program Ruby Khatun Khatun14 Sept 2017 10:02 AM ISTCORK, Ireland: Janssen Sciences Ireland UC (Janssen), announced a strategic decision to discontinue further development of the investigational...
